HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 3 of 3
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Mizugaki, Hidenori; Shinagawa, Naofumi; Kanegae, Kakuko; Yamada, Noriyuki; Asahina, Hajime; Kikuchi, Eiki; Oizumi, Satoshi; Tamaki, Nagara; Nishimura, MasaharuCombining transbronchial biopsy using endobronchial ultrasonography with a guide sheath and positron emission tomography for the diagnosis of small peripheral pulmonary lesions-Lung Cancer-May-2010
article (author version)Asahina, Hajime; Oizumi, Satoshi; Inoue, Akira; Kinoshita, Ichiro; Ishida, Takashi; Fujita, Yuka; Sukoh, Noriaki; Harada, Masao; Maemondo, Makoto; Saijo, Yasuo; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nukiwa, Toshihiro; Nishimura, MasaharuPhase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib-Oncology : International Journal for Cancer Research and Treatment-Apr-2011
article (author version)Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)Cancer chemotherapy and pharmacology-Nov-2017
Showing results 1 to 3 of 3

 

Feedback - Hokkaido University